TAB2 and cardiac hypertrophy: Previous research has demonstrated that reactive oxygen species generated during cardiac hypertrophy progression can induce the auto-ubiquitination of TRAF6, leading to the recruitment of TAB2 and the subsequent binding to TAK1, thereby activating the TAK1-mediated prohypertrophic signaling pathway [80].